Bridgewater, MA -- (SBWIRE) -- 03/26/2013 -- The Automated StockConsultant screener has found a biotech company that provides drugs for central nervous system disorders ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) stock under a breakout watch above 8.57 to new highs.
ACAD stock price was up a big 9.8% yesterday to 8.31 and is on the verge of a continuation breakout above 8.57 with a target of 10.16 for a gain of 22.3%. The stock continues to act strong following a breakout last week and looks ready to resume its uptrend, continue reading the bullish breakout report and follow the move higher.
StockConsultant.com provides automated stock consulting reports and an advanced screener on over 6000 US equities. Each detailed stock report contains easy to use technical analysis indicators, charts, and news to fine tune stock entry and exit price levels. Completing the tools is a daily "Stocks to Watch" list, real-time portfolio (show up to 35 stock charts simultaneously) and keyboard controlled QuickCharts.
StockConsultant.com and its employees are not registered investment advisors and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Please check with a registered investment advisor before making any investment decisions.
For our full disclaimer please visit http://www.stockconsultant.com/disclaimerpage.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)